Emmes Launches Cell and Gene Therapy Center to Support Its Client’s Clinical Trials
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
The new center will emphasis on supporting the clinical trials of its clients who are developing cell and gene therapies around the world and across multiple therapeutic areas, including hematology, oncology, cardiology and ophthalmology, as well as rare diseases. The center will combine a team of 100 researchers to capitalize on the company’s 35 years of cell and gene therapy experience. The Cell and Gene Therapy Center follows the successful launch of Emmes’ Rare Disease Center last year.
The center will offer Emmes’ full complement of research services, with expertise in clinical trial operations, study leadership, statistical services, data management, and pharmacovigilance. Regulatory, training, and educational support will continue to expand.
Founded more than 45 years ago, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation